Caroline Bret - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Caroline Bret

Showing results (41-50 of 46) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 46 results.

Blood|February 26, 2026

Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHLPaul Marcoux, Fabien Gava, Marie Tosolini, et al.

Blood Neoplasia|June 2, 2025

Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myelomaLaure Dutrieux, Sara Ovejero, Antoine Guillemin, et al.

Cancers|September 10, 2021

Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell TherapySylvain Lamure, François Van Laethem, Delphine De Verbizier, et al.

American Journal of Hematology|July 4, 2026

High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1Orianne Wagner-Ballon, Anne-Catherine Lhoumeau, Anna Raimbault, et al.

Haematologica|June 20, 2024

Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registryCharles Herbaux, Caroline Bret, Emmanuel Bachy, et al.

Blood Advances|December 24, 2019

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.

Pageof 5

Search research articles

Showing results (41-50 of 46) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 46 results.

Blood|February 26, 2026

Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHLPaul Marcoux, Fabien Gava, Marie Tosolini, et al.

Blood Neoplasia|June 2, 2025

Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myelomaLaure Dutrieux, Sara Ovejero, Antoine Guillemin, et al.

Cancers|September 10, 2021

Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell TherapySylvain Lamure, François Van Laethem, Delphine De Verbizier, et al.

American Journal of Hematology|July 4, 2026

High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1Orianne Wagner-Ballon, Anne-Catherine Lhoumeau, Anna Raimbault, et al.

Haematologica|June 20, 2024

Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registryCharles Herbaux, Caroline Bret, Emmanuel Bachy, et al.

Blood Advances|December 24, 2019

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.

Pageof 5